Latest Breaking News On - மருத்துவ சோதனைகள் ஆஂடேரியொ - Page 1 : comparemela.com

Edesa Biotech to Join Panel Discussion at Government COVID-19 Event TORONTO, ON / ACCESSWIRE / January 20, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to participate in a virtual event organized by Clinical Trials Ontario in collaboration with the Bureau du Québec à Toronto and the Canadian and International Innovation Partnerships Directorate. As part of a government and industry panel, Dr. Nijhawan is expected to discuss the importance of developing multiple countermeasures to the COVID-19 pandemic, including therapies, like Edesa s EB05 drug candidate, that target the overactive host immune response in COVID-19 patients.

California
United-states
Canada
Toronto
Ontario
Canadian
Gary-koppenjan
Edesa-biotech-inc
International-innovation-partnerships-directorate
Bureau-du-qu
Nasdaq
Edesa-biotech